General Information of This Drug (ID: DMCIJBH)

Drug Name
DU-176b   DMCIJBH
Synonyms Edoxaban
Indication
Disease Entry ICD 11 Status REF
Atrial fibrillation BC81.3 Approved [1]
Drug Type
Small molecular drug
Structure
3D MOL is unavailable 2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

7 Clinical Trial Drug Combination(s) Consisting of This drug
DrugCom Name DrugCom ID Component Drug Indication REF
Apixaban + DU-176B DCCZT3O Apixaban Atrial Fibrillation [2]
DU-176B + Aspirin DC444VB Aspirin Peripheral Arterial Disease [3]
DU-176B + Clopidogrel DCMNVOC Clopidogrel SCAD [4]
DU-176B + Aspirin DCMTCPA Aspirin SCAD [4]
Apixaban + DU-176B DCQGYWA Apixaban Aortic Stenosis [5]
DU-176B + Colchicine DCOVCXI Colchicine SARS-CoV Infection [6]
DU-176B + Aspirin DC3FDGY Aspirin Coronary Artery Disease [7]
------------------------------------------------------------------------------------
⏷ Show the Full List of 7 DrugCom(s)

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7575).
2 ClinicalTrials.gov (NCT05262322) Study to Evaluate the Use of Direct Oral Anticoagulants in UK Clinical Practice For Patients With a First Stroke Attributable to Nonvalvular Atrial Fibrillation
3 ClinicalTrials.gov (NCT01802775) Edoxaban in Peripheral Arterial Disease
4 ClinicalTrials.gov (NCT05122455) Effects of Edoxaban on Platelet Aggregation
5 ClinicalTrials.gov (NCT05035277) AntiCoagulation Versus AcetylSalicylic Acid After Transcatheter Aortic Valve Implantation
6 ClinicalTrials.gov (NCT04516941) CorONa Virus edoxabaN ColchicinE (CONVINCE) COVID-19
7 ClinicalTrials.gov (NCT02567461) Edoxaban in Patients With Coronary Artery Disease on Dual Antiplatelet Therapy With Aspirin and Clopidogrel